CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stelmach, I.
Right arrow Articles by Dziadek, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stelmach, I.
Right arrow Articles by Dziadek, J.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, October 2005, p. 1246-1250, Vol. 12, No. 10
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.10.1246-1250.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Humoral and Cellular Immunity in Children with Mycoplasma pneumoniae Infection: a 1-Year Prospective Study

Iwona Stelmach,1* Malgorzata Podsiadlowicz-Borzecka,1 Tomasz Grzelewski,1 Pawel Majak,1 Wlodzimierz Stelmach,2 Joanna Jerzynska,1 Marta Poplawska,3 and Jaroslaw Dziadek3

M. Curie Hospital, Department of Pediatrics and Allergy, Zgierz, Poland,1 Regional Health Insurance Fund, Lodz, Poland,2 Center for Medical Biology, Polish Academy of Sciences, Lodz, Poland3

Received 1 April 2005/ Returned for modification 18 June 2005/ Accepted 25 July 2005

To determine whether children have persistent abnormalities in cellular and humoral immunity development after acute Mycoplasma pneumoniae infection, serum immunoglobulin G (IgG), IgA, IgM, and IgE levels and lymphocyte phenotypes were determined. There were no changes in the levels of IgG, IgM, IgA, or CD4+ or CD19+ lymphocytes that were measured in M. pneumoniae-positive patients after 3 months or after 12 months, but there were increases in these in M. pneumoniae-negative patients. Serum IgE increased in M. pneumoniae-positive patients. We have shown alterations in immunity development after M. pneumoniae infection.


* Corresponding author. Mailing address: M. Curie Hospital, Department of Pediatrics and Allergy, 35 Parzeczewska Str., 95-100 Zgierz, Poland. Phone: (48 42) 716 49 82. Fax: (48 42) 716 49 82. E-mail: interna{at}wss.zgierz.pl.


Clinical and Diagnostic Laboratory Immunology, October 2005, p. 1246-1250, Vol. 12, No. 10
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.10.1246-1250.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.